Dr. Frank Weinberg
Claim this profileUniversity of Illinois
Area of expertise
Lung Cancer
Frank Weinberg has run 11 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Frank Weinberg has run 9 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of Illinois
University Of Illinois Cancer Center
Clinical Trials Frank Weinberg is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
Olomorasib
for Non-Small Cell Lung Cancer
The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo combination in part A in participants with resected KRAS G12C-mutant NSCLC and to assess if olomorasib in combination with durvalumab is more effective than the durvalumab and placebo combination in part B in participants with unresectable KRAS G12C-mutant non-small cell lung cancer. The study may last up to 3 years for each participant.
Recruiting
1 award
Phase 3
8 criteria
More about Frank Weinberg
Clinical Trial Related
5 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 7 Active Clinical Trials
Treatments Frank Weinberg has experience with
- Pembrolizumab
- Carboplatin
- Pemetrexed
- Paclitaxel
- Durvalumab
- Nab-paclitaxel
Breakdown of trials Frank Weinberg has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Lung Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Frank Weinberg specialize in?
Frank Weinberg focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Frank Weinberg currently recruiting for clinical trials?
Yes, Frank Weinberg is currently recruiting for 7 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Frank Weinberg has studied deeply?
Yes, Frank Weinberg has studied treatments such as Pembrolizumab, Carboplatin, Pemetrexed.
What is the best way to schedule an appointment with Frank Weinberg?
Apply for one of the trials that Frank Weinberg is conducting.
What is the office address of Frank Weinberg?
The office of Frank Weinberg is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.